Copy to clipboard 
Marle Group acquired France-based Nowak. The Marle Group now has 13 production facilities globally that are exclusively focused on orthopedic, trauma and spine implants and instruments, and surgical robotics manufacturing for OEMs worldwide.
This acquisition adds two new French facilities to Marle’s portfolio: Marle Nowak in Pancé, a medical casting location, and Marle Belmonte in Valence, which is a medical device manufacturing location mainly focused on machining and finishing of orthopedic implants. Both facilities are ISO 9001 and ISO 13485 certified with robust quality systems.
Marle now has eight facilities in France, one Swiss and four U.S. facilities to support its global customers. Marle Group will continue to make strategic acquisitions and partnerships to expand its value-added portfolio for its OEM customers. Recent transactions included the purchases of Elite Medical, Tangible Solutions and 3D MEDLAB.
Heimo Wabusseg, CEO of Marle Group, said, “We are excited to add Marle Nowak and Marle Belmonte to our Marle family and are aligned on our mutual focus on collaborating with our customers to manufacture products that provide better patient outcomes. Our Marle focus on technology, quality and innovation makes this acquisition a perfect fit for our continued growth in supporting OEMs worldwide.”
Frank D. Noone, Vice President of Marle America, said, “Marle Nowak gives our customers more capacity and redundancy in the medical casting space. These two great facilities add additional complex manufacturing capacity and strengthen our position as one of the top medical device contract manufacturers globally. We are proud to be serving the global orthopedics industry with the world’s finest implants and instruments.”
Source: Marle Group
